Top Markets
Coin of the day
Response Genetics, Inc Response Genetics, Inc

Response Genetics, Inc

RGDXQ
株式のランク #42156
Response Genetics, Inc., a life sciences company founded in Los Angeles,... Response Genetics, Inc., a life sciences company founded in Los Angeles, California, in 1999 (originally Bio Type, Inc., before its rebranding in August 2000), focuses on creating, advancing, and commercializing pharmacogenomic tests. These diagnostic tools are crucial for informing cancer treatment decisions by assessing specific indicators within tumor tissue samples that predict a patient's response to therapy. The company provides an extensive array of testing services, primarily through its ResponseDX suite, covering various cancers such as non-small cell lung, colorectal, gastric, gastroesophageal, melanoma, thyroid, breast, and glioma, in addition to a Tissue of Origin test. Beyond these existing solutions, Response Genetics is committed to expanding its diagnostic offerings to encompass other tumor types, while also delivering both the technical execution and professional interpretation components of its testing services. Operating globally, with a significant presence in the United States and Europe, Response Genetics serves a wide range of clients including community oncologists, pathologists, medical practices, hospitals, and pharmaceutical enterprises, primarily through its internal sales force.
株価
$0.0001
最終同期: 2026-08-11
時価総額
$3.87K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Response Genetics, Inc (RGDXQ)

カテゴリー

Response Genetics, Inc(RGDXQ)の株式分割履歴
Response Genetics, Inc株(シンボル:RGDXQ)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 13, 2026に行われました。
Aug 13, 2026より前に購入されたRGDXQ株は、現在0RGDXQ株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
8 x34
US
7 x47
US
0 -
CN
4 x15
US
0 -
US